author-photo

Mark Linch

University College London
The Royal Marsden NHS Foundation Trust

72

Papers

1121

Citations

Citation Trend

Filter By

Papers (54) Sort By

Journal Conference Others

BXCL701, first-in-class oral activator of systemic innate immunity pathway, combined with pembrolizumab (Keytruda) in men with metastatic castration-resistant prostate cancer (mCRPC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
610P BXCL701 - 1st-in-class oral activator of systemic innate immunity-combined with pembrolizumab, in men with metastatic castration-resistant prostate cancer (mCRPC): Phase II results

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB004: Nivolumab (NIVO) and ipilimumab (IPI) treatment in prostate cancer with an immunogenic signature: cohort 1 of the NEPTUNES multi-centre, two-stage biomarker-selected Phase II trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial

2021 European Urology Oncology
Show All
- Source
- Cite
- Save
Citations (3)
351 KEYNOTE-365 cohort D: pembrolizumab plus abiraterone acetate and prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC)

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat

2020 European Urology
Show All
- Source
- Cite
- Save
Citations (4)
Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (11)
Equivocal, explicit and emergent actions of PKC isoforms in cancer.

2020 Nature Reviews Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

2020 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (0)